Oxurion Provides Update on Clinical Pipeline Progress : vima

Completed Patient Enrollment for Part A of Phase 2 INTEGRAL Trial Evaluating THR-687 for treatment of Diabetic Macular Edema (DME) in treatment naïve...

Related Keywords

Boston , Massachusetts , United States , Nevada , Leuven , Region Flamande , Belgium , Reno , Tom Graney , Arshadm Khanani , Clinical Research At Sierra Eye Associates , Completed Patient Enrollment , Diabetic Macular Edema , Protocol Amendment , Euronext Brussels , Age Related Macular Degeneration , Retinal Vein Occlusion , Chief Executive Officer , Received Approval , Review Board , Best Corrected Vision , Clinical Research , Sierra Eye Associates , Brussels Stock Exchange Oxur , Oxurion Nv ,